SEARCH
Current Location:
>
> This Story

Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More News Headlines

AirXpanders Completes Enrollment in XPAND US Pivotal Trial Preliminary Study Results Highlight Benefits of World's First Patient-Controlled Tissue Expansion System for Women Undergoing Breast Reconstruction

MD Buyline Reports: Carestream Earns Highest Rating for DRX-Revolution Mobile Systems and Room-Based DRX Systems

Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion ablation within Intraoperativ

Elekta to deliver advanced cancer management solutions to Providence Health & Services

aycan integrated RIS/PACS solution chosen by Radiology Consultants of the Midwest; provides highly efficient, cost effective rad

TeraRecon Highlights iNteract+ Imaging Workflows at HIMSS15

INFINITT North America signs Seattle Children’s Hospital for 10-year Partnership Agreement Agreement includes INFINITT’s latest PACS Technology and Next-generation Vendor Neutral Archive

Medtronic to Develop Stent Graft System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms Under Exclusive Patent Lice

Capsule Introduces Healthcare's First Analytics Solution to Utilize Data Across All Connected Medical Devices

At HIMSS 2015, Siemens Underscores Commitment to Healthcare IT Business

Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND

Newly Improved Peripheral IV Catheter Is Blood-Drawable, Power-Injectable, and Can Deliver Therapy for Entire Length of Stay

SAN DIEGO -- Access Scientific, Inc. announced it has received FDA 510(k) clearance for the 4Fr Nanopuncture™ POWERWAND®. The unique peripheral IV catheter (technically a midline at 3.1 inches) is lighter and designed to provide smoother handling and even greater ease of insertion.

Story Continues Below Advertisement

Fully integrated PACS, RIS and Voice Recognition at an affordable price

We fit our RIS/PACS to match your workflow, rather than the other way around! Call us at 866-949-7227 or click here to visit our website & see our Advanced Mammography Workstations & Mammography Tracking System built into RIS



The 4Fr Nanopuncture POWERWAND is, like the previously FDA-cleared 5Fr version, a power-injectable, peripheral IV catheter that is inserted using the proprietary Accelerated Seldinger Technique.

The POWERWAND can be used both for the administration of fluids/medications and for withdrawing blood for diagnostic tests. It is the first and only power-injectable peripheral IV (PIV) catheter capable of delivering continuous IV therapy for the patient's entire length of hospital stay. The device may be left in place for up to 29 days per its FDA clearance. It is also designed to be an integral part of any program to reduce central-line associated bloodstream infections (CLABSI).

The catheter has been well received by hospitals using it. "The 4Fr version gives the vascular access team more options. An extended-dwell catheter that can be placed both in the upper arm with ultrasound, or in the lower arm or forearm without using ultrasound, is the bridge we needed between the peripheral IV and the PICC. Sometimes with vascular access we need as many options as we can get," said Peter Hobday, RN, CCRN, CRNI, Director of the Vascular Access team at Brotman Medical Center, in Culver City, Calif.

The POWERWAND's versatility makes it the first and best choice for many patients, said Steve Bierman, M.D., president and CEO of Access Scientific.

"CDC Guidelines now say that patients whose IV therapy will likely exceed six days should have a midline or, if -- and only if - indicated, a central line," Dr. Bierman said. "Based on recent studies, this means that nearly 30% of hospitalized patients should have a POWERWAND."

In addition to allowing consistent blood draws, the catheter has a flow rate of 130 mL per minute -- making it by far the fastest-flowing peripheral line of its size. "This rapid flow rate capability translates into lives saved in the emergency department, OR and ICU," said Dr. Bierman.

The POWERWAND has several notable safety features:

* Alternative to central lines. Because it is not a central line, the catheter does not carry the same high risk of potentially fatal bloodstream infections. Midline catheters such as the 4Fr Nanopuncture POWERWAND have the lowest published bloodstream infection rate of all inpatient vascular access devices.

Continue reading Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED